Giovanni Abbadessa

Giovanni Abbadessa

Company: Sanofi

Job title: Global Head of Oncology Early Development, & Global Project Head, peg-IL-2 (THOR-707/ SAR444245)

Seminars:

Development of SAR444245 (THOR-707) & Considerations for NK Cells & Immune Engager Combinations 1:00 pm

Read more

day: Day Two

Group Panel Discussion: Side Effects – Mitigating Against Hypotension + Fever With Immune-Stimulating Agents (NK Cell Engagers, PD-1s, Cytokines, T-Cell Engagers) = Cytokine Release Syndrome (CRS)? 11:30 am

What are the differences between the symtoms and the tests Uncover the implications for patients and regulatory bodies Examine the Implications for CAR-T Could this redefine CRS?Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.